These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7120278)

  • 1. Quantitative structure-activity relationship by distance geometry: quinazolines as dihydrofolate reductase inhibitors.
    Ghose AK; Crippen GM
    J Med Chem; 1982 Aug; 25(8):892-9. PubMed ID: 7120278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined distance geometry analysis of dihydrofolate reductase inhibition by quinazolines and triazines.
    Ghose AK; Crippen GM
    J Med Chem; 1983 Jul; 26(7):996-1010. PubMed ID: 6864738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General distance geometry three-dimensional receptor model for diverse dihydrofolate reductase inhibitors.
    Ghose AK; Crippen GM
    J Med Chem; 1984 Jul; 27(7):901-14. PubMed ID: 6737433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of dihydrofolate reductase: structure-activity correlations of quinazolines based upon molecular shape analysis.
    Battershell C; Malhotra D; Hopfinger AJ
    J Med Chem; 1981 Jul; 24(7):812-8. PubMed ID: 7277385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of dihydrofolate reductase. Structure-activity correlations of quinazolines.
    Fukunaga JY; Hansch C; Steller EE
    J Med Chem; 1976 May; 19(5):605-11. PubMed ID: 1271401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of dihydrofolate reductase: structure-activity correlations of 2,4-diamino-5-benzylpyrimidines based upon molecular shape analysis.
    Hopfinger AJ
    J Med Chem; 1981 Jul; 24(7):818-22. PubMed ID: 7277386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinazolines as inhibitors of dihydrofolate reductase. 1.
    Ashton WT; Walker FC; Hynes JB
    J Med Chem; 1973 Jun; 16(6):694-7. PubMed ID: 4715004
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative structure-activity relationships by distance geometry: systematic analysis of dihydrofolate reductase inhibitors.
    Crippen GM
    J Med Chem; 1980 Jun; 23(6):599-606. PubMed ID: 7392027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinazolines as inhibitors of dihydrofolate reductase. 4. Classical analogues of folic and isofolic acids.
    Hynes JB; Eason DE; Garrett CM; Colvin PL
    J Med Chem; 1977 Apr; 20(4):588-91. PubMed ID: 850245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinazolines as inhibitors of dihydrofolate reductase. 2.
    Hynes JB; Ashton WT
    J Med Chem; 1974 Sep; 17(9):1023-5. PubMed ID: 4213339
    [No Abstract]   [Full Text] [Related]  

  • 11. Antifolate and antibacterial activities of 5-substituted 2,4-diaminoquinazolines.
    Harris NV; Smith C; Bowden K
    J Med Chem; 1990 Jan; 33(1):434-44. PubMed ID: 2404122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative structure-activity relationships of antimalarial and dihydrofolate reductase inhibition by quinazolines and 5-substituted benzyl-2,4-diaminopyrimidines.
    Hansch C; Fukunaga JY; Jow PY
    J Med Chem; 1977 Jan; 20(1):96-102. PubMed ID: 319234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.
    Ghose AK; Crippen GM
    J Med Chem; 1985 Mar; 28(3):333-46. PubMed ID: 3882967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibitors of Candida albicans dihydrofolate reductase: activity and selectivity of 5-(arylthio)-2,4-diaminoquinazolines.
    Chan JH; Hong JS; Kuyper LF; Baccanari DP; Joyner SS; Tansik RL; Boytos CM; Rudolph SK
    J Med Chem; 1995 Sep; 38(18):3608-16. PubMed ID: 7658448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the biological effects of selected 5,8-dideazafolate analogues with their 2-desamino counterparts.
    Hynes JB; Patil SA; Hagan RL; Cole A; Kohler W; Freisheim JH
    J Med Chem; 1989 Apr; 32(4):852-6. PubMed ID: 2704031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distance geometry approach to rationalizing binding data.
    Crippen GM
    J Med Chem; 1979 Aug; 22(8):988-97. PubMed ID: 490543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of quinespar, a quinazoline analogue of methotrexate.
    Mastropaolo D; Smith HW; Camerman A; Camerman N
    J Med Chem; 1986 Jan; 29(1):155-8. PubMed ID: 3941409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinazoline antifolate thymidylate synthase inhibitors: 2'-fluoro-N10-propargyl-5,8-dideazafolic acid and derivatives with modifications in the C2 position.
    Jackman AL; Marsham PR; Thornton TJ; Bishop JA; O'Connor BM; Hughes LR; Calvert AH; Jones TR
    J Med Chem; 1990 Nov; 33(11):3067-71. PubMed ID: 2231607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of a methotrexate-insensitive dihydrofolate reductase from L5178Y cells by substituted triazines and quinazolines.
    Dedhar S; Freisheim JH; Hynes JB; Goldie JH
    Biochem Pharmacol; 1983 Mar; 32(5):922-4. PubMed ID: 6838639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2,4-Diamino-5-substituted-quinazolines as inhibitors of a human dihydrofolate reductase with a site-directed mutation at position 22 and of the dihydrofolate reductases from Pneumocystis carinii and Toxoplasma gondii.
    Rosowsky A; Mota CE; Queener SF; Waltham M; Ercikan-Abali E; Bertino JR
    J Med Chem; 1995 Mar; 38(5):745-52. PubMed ID: 7877140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.